Congress passes drug review act
Article Abstract:
Congress has approved a bill that will allow the FDA to charge drug firms for reviewing new drugs. The prescription drug industry is in favor of the law, which will help the FDA approve drugs more quickly and increase the earnings of drug companies.
Publisher: Facts on File, Inc.
Publication Name: Facts on File
Subject: Business, general
ISSN: 0014-6641
Year: 1992
Drugs, User fees
Publication Name: Facts on File
Subject: Business, general
ISSN: 0014-6641
Year: 1992
User Contributions:
Comment about this article or add new information about this topic:
Alzheimer's drug rejected
Article Abstract:
An advisory panel of the Food and Drug Administration on Nov 2, 1992, decided that the drug Mentane should not be approved for the treatment of Alzheimer's Disease. The panel had questions about the drug's safety and effectiveness.
Publisher: Facts on File, Inc.
Publication Name: Facts on File
Subject: Business, general
ISSN: 0014-6641
Year: 1992
Drug therapy, Alzheimer's disease, Anti-Alzheimer's disease agents
Publication Name: Facts on File
Subject: Business, general
ISSN: 0014-6641
Year: 1992
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: Laws, regulations and rules, United States. Food and Drug Administration
Similar abstracts:
- Abstracts: The management of intellectual assets: a new corporate perspective. How to control a joint venture even as a minority partner
- Abstracts: Federal 'gag rule' eased. 'Gag rule' rejected by appeals court. Eased controls spur high-tech imports
- Abstracts: Elections set amid strife as talks fail. Opposition peace proposals rejected
- Abstracts: Defense fund challenge dismissed. Fox promises candidates free air time. Candidates report on finances
- Abstracts: Pension-plan advisers' liability limited. Seizure challenges limited
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.